Tests a heart prevention program for people with high blood pressure and cholesterol
Tests a behavior-change program aimed at improving blood pressure and cholesterol in adults.
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Registry title
- Penn Medicine Healthy Heart
- Status
- Recruiting
- People taking part
- 1,980 people, planned
- Started
- 11 Mar 2024
- Expected to end
- Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Penn Med Healthy Heart Program
- Record updated
- 12 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Penn Medicine primary care patients with high blood pressure and a raised risk of heart disease or high cholesterol. It tests a heart disease prevention program over 6 months.
- Age
- 35 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Last 2 blood pressure readings with top number (systolic) of 140 or higher in the last 12 months. Also heart or blood vessel disease from fat build-up (ASCVD), or an ASCVD risk score of 10% or more, or diabetes (including A1c 6.5 or higher in the last year), or LDL cholesterol of 190 or higher in the past five years.
- Earlier treatment
- Not on a statin, PCSK9 inhibitor or Inclisiran. Or on a low- or moderate-intensity statin with LDL above 100.
- Biomarker or test result
- Blood pressure, LDL cholesterol and A1c results as listed above.
Main reasons for not taking part
- On a PCSK9 inhibitor
- Statin allergy or intolerance noted in the medical record
- Pregnant or breastfeeding
- Much shorter life expectancy (for example metastatic cancer, hospice, end stage kidney disease, heart failure, dementia)
- Needs a translator because of not speaking English, or has no cell phone
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- On the Penn Medicine Primary Care Service Line registry
- Last 2 Blood Pressure readings with Systolic Blood Pressure >=140 from any outpatient encounter in the last 12 months AND
- ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
- Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL >100
Who cannot take part
- Patients on PCSK9 inhibitors
- Documented statin allergy/ or intolerance in the EMR
- Markedly shortened life expectancy including:; metastatic cancer; hospice; End Stage Renal Disease; Congestive Heart Failure; Dementia
- Pregnancy
- Breast feeding
- Is a non-English speaker requiring a translator
- Patients who do not have a cell phone
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 80 years old?
Where in United States
- Penn MedicinePhiladelphia, United StatesContact: Laurie A Norton, MA, MBETaking people
About the trial
What the trial wants to find out
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.
The 2 groups in the trial
- Usual CareNo study treatment, for comparison
This group will not receive the intervention and will continue with usual care.
- Penn Med Healthy Heart ProgramTreatment being tested
The Intervention group will receive the blood pressure monitor and move through the 4 HDPP modules of the intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reducing Atherosclerotic Cardiovascular Disease (ASCVD) Through a Comprehensive Heart Disease Prevention Program (HDPP)
- Plain-language title
- Tests a heart prevention program for people with high blood pressure and cholesterolGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06062394, who can take part
- Publications
- Record updated
- 12 March 2026